Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,363 public trials 405 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab

NCT01515189

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • The Angeles Clinic And Research Institute Los Angeles, California, United States
  • University Of California Los Angeles Los Angeles, California, United States
  • Baptist Cancer Institute Jacksonville, Florida, United States
  • Orlando Health, Inc Orlando, Florida, United States
View all 88 locations
View Trial Details
Completed

A Study of Vemurafenib and GDC-0973 (Cobimetinib) in Participants With BRAFV600E Mutation-Positive Metastatic Melanoma

NCT01271803

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • The Angeles Clinic and Research Institute, Santa Monica Office Santa Monica, California, United States
  • University of Colorado; Anschutz Cancer Pavilion Aurora, Colorado, United States
View Trial Details
Completed

A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma

NCT01667419

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UCLA Department of Medicine; Division of Hematology / Oncology California City, California, United States
  • Kaiser Permanente - Hayward Hayward, California, United States
  • UCLA Hematology Oncology - Irvine Irvine, California, United States
View all 207 locations
View Trial Details
Completed

A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )

NCT01227551

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Moores UCSD Cancer Center La Jolla, California, United States
  • St Mary's Medical Center San Francisco, California, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details

Related conditions